Remote patient monitoring platform Huma Therapeutics has announced two major milestones today (May 16).
The company has revealed details of a global partnership agreement with Eckuity Capital to develop next-generation technology infrastructure for the acquisition and launch of digital solutions in healthcare and research.
This strategic collaboration aims to provide the resources necessary to advance Huma’s aggressive M&A strategy, with the goal of acquiring complementary companies to build a comprehensive digital ecosystem supporting health systems, pharmaceutical companies, CROs, and patients worldwide.
Huma has also acquired Aluna (also known as Knox Medical Diagnostics, Inc.), a US-based company specialising in intelligent remote monitoring and management of respiratory diseases.
Youssef Sebban, Managing Partner at Eckuity Capital, said: “We help Huma acquire companies that, on their own, may not fully realise their potential—but when integrated into Huma’s cloud platform, become highly complementary and transformative.
“This synergy not only amplifies their impact on the healthcare ecosystem but also drives outsized value creation for investors and shareholders.”
Huma’s disease-agnostic cloud platform has earned major regulatory certifications, including FDA 510(k) Class II and EU MDR Class IIb status.
It supports over 4,500 hospitals and clinics and engages more than 50 million individuals across 70+ countries.
Huma plays a pivotal role in national healthcare initiatives across the US, UK, Germany, Greece, and Saudi Arabia, partnering with health systems, pharmaceutical companies, and CROs to redefine healthcare delivery.
Dan Vahdat, Founder and CEO of Huma, said: “Today’s announcements mark a new chapter for Huma as we strive to build the most impactful healthcare company in the world.
“By integrating Aluna’s leading respiratory monitoring solutions into our platform and working to secure growth capital for further acquisitions, we are creating a complete ecosystem to deliver even greater value to health systems, life sciences, and—most importantly—patients around the world.”
Photo: Front row left right: Charvi Shetty CEO of Aluna with Dan Vahdat CEO of Huma
